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In recent years, nanoparticles have been applied to and have gained prevalence in 
fields such as chemistry, biology, the medical sciences, and biotechnology,
1 
and have 
attracted the attention of medical researchers as potential microscopic drug delivery 
systems in the human body.
2
 In particular, nanoparticles made with the lanthanides have 




Because nanomaterials may be engineered to be between 1 and 100 nm in size, 
they are being explored for use in biological applications within the human body. In order 
for materials to be of use in the body, they must be small enough to leave through the 
kidneys,
2
 and therefore 6 nm or smaller-sized particles are ideal.
3
 These small particles 
have large surface area to volume ratios, and can therefore carry relatively large amounts 
of other materials, such as small molecules with pharmacological effects, on their 
surface.
2
 This opens up the possibility for use in cellular therapy, gene therapy, 
immunizations, and detoxification,
4
 and these small particles may be used for the delivery 
of drugs to the body.
2,4-6
 These particles may also function in the field of oncology to aid 
in both visualizing and destroying cancerous tumors.
2,7
  
Nanomaterials may be constructed of many different elemental compositions. Of 
particular interest are lanthanide nanoparticles, as the lanthanides have shown themselves 
to be useful in nanotechnology in a variety of ways. Applications include the detection of 
DNA concentration as low as 2 µg/mL,
8
 use in fluorescent resonant energy transfer 
(FRET) as a method to detect interactions between proteins,
8,9 
and efficient single-protein 
detection that has higher specificity than the most common method used for such 
detection, enzyme-linked immunoabsorbent assay (ELISA).
8
 In addition, lanthanide 
 2 
nanoparticles have shown potential in anti-fraud techniques as optical barcodes or 
markers on banknotes and important documents,
10
 and have been explored for uses in 
such items as lasers and luminescent displays.
11 
A promising use for lanthanide nanoparticles is in imaging techniques. 
Lanthanide nanoparticles not only have promising optical properties, but also exhibit low 
cytotoxicity to cells which is crucial if they are to be biologically relevant.
2,4
 Current 
imaging techniques face limitations due to the optical properties of the probes that are 
used which may not be ideal for distinguishing signal,
8
 and because assays based on 
luminescence are fundamental to bioimaging techniques,
12
 there is interest in creating 
probes that are more efficient and have higher sensitivity than probes already commonly 
in use. For example, green fluorescent protein (GFP) is a stain commonly used to 
visualize biomaterials of interest. However, GFP is imperfect because it loses 
luminescence over time as a consequence of instrumental photobleaching.
2,8
 The 
lanthanides, in contrast, are resistant to photobleaching and also have well-defined, 
narrow emission bands, such that they may easily be distinguished from other 
background fluorescence.
2,12 
Multiple lanthanide ions can be co-doped into nanoparticles at various relative 
concentrations. Lanthanide-doped nanoparticles, which have a specific amount of a 
lanthanide element bound in their crystal structure, have several unique properties. These 
include high photostability
1,8,12,13
 and long lifetimes as a result of the forbidden 
transitions among f-electron configurations.
8
 In addition, these particles possess large 
Stokes shifts,
14
 meaning that there is a large separation between the wavelength of 




Additionally, the lanthanides possess luminescent properties, also a 
result of the forbidden transitions among the f-electron configuration of the lanthanide 
ion.
8,9,15
 Europium ions (Eu
3+)
, terbium ions (Tb
3+
), and gadolinium ions (Gd
3+
) are 
unique in that they luminesce in every chemical environment, independent of the solvent 
they are in as well as other ions they are bound to.
11,16
 In addition, many lanthanide ions 
(Ln
3+
) have at least two luminescent states
11
 that can be utilized for analytical purposes.  
 Not only do the lanthanides have special optical properties, but they also have 
notable magnetic properties.
13,17
 Many of the lanthanide ions have a relatively large 




 having seven unpaired electrons, and 
this leads to a high magnetic moment, allowing for these magnetic properties to be 
utilized. Magnetic resonance imaging (MRI) contrast agents yield a brighter MRI signal 





 is the most commonly used MRI contrast agent because of its 
high magnetic moment.
4,18
 Since MRI contrast agents rely on magnetic properties, the 
lanthanides are being further explored as efforts are made to create improved contrast 
agents with increased sensitivity. 
All of the fifteen lanthanide elements form stable tripositive ions and may be 
substituted for one another in a crystal lattice with little change in the crystal 
structure.
11,14
 For this reason, lanthanum salt crystals may be doped with other 
lanthanides, which may be used to quantify concentration of the nanoparticles when the 




 are less 
sensitive to vibrational quenching of luminescence by other vibrating molecules than are 
other lanthanide ions,
14
 and thus may be most useful for this application. 
 4 
 Nanoparticles have attracted the attention of scientists for use with medical 
applications due to their ability to serve as drug delivery systems in the human body. 
However, in order for these particles to be utilized for these purposes, many conditions 
must be met; for this reason it is important to have methods to alter the shape, size, 
optical properties, and various other properties of nanoparticles. These properties may be 
controlled during synthesis by changing ionic strength, solvent used, dopant amounts, 
temperature, and pH. In this study, lanthanum fluoride (LaF3), lanthanum chloride 
(LaCl3), and lanthanum phosphate (LaPO4) nanocrystals were synthesized under varied 
pH synthesis conditions. A capping group, o-phosphorylethanolamine, was used during 
synthesis to bind to the crystals, causing them to stop growing and keeping them on the 
nanoscale. Figure 2 demonstrates our hypothesis of how the capping group binds to the 
lanthanides in the crystal structure to stop crystal growth. 
                                                                        
Figure 1. Possible binding of o-phosphorylethanolamine to lanthanide in crystal lattice. 
 
  It was hypothesized that nanocrystals synthesized in low pH conditions would be 
larger in size than those formed in higher pH solutions because the capping group, o-
phosphorylethanolamine can be protonated at low pH values, preventing quick binding to 
the growing nanocrystals. It is crucial to determine optimum synthetic parameters so that 
nanoparticles are both small enough to pass through the kidneys and also have the ability 
to attach different functional groups so that they may be relevant to pharmaceutical 
Ln 
 5 
applications. The size distribution of terbium-doped lanthanide nanocrystals based upon 
varied counterions (fluoride, chloride, and phosphate) and pH conditions (pH 2-7) was 
quantified using the unique luminescent properties of terbium, and furthermore the 
quantum yield, or efficiency at emitting light, of these nanocrystals was explored using 




The lanthanide salts (Tb(NO3)3 · 6H2O and La(NO3)3 · 6H2O) were purchased from Alfa 
Aesar and used without further purification. The capping group solution (o-
phosphorylethanolamine) and the sodium salts (NaF, NaCl, and Na3PO4) were purchased 
from Sigma Aldrich and also used without further purification. The centrifuge tubes with 
membranes used for size separation were 3 K, 10 K, 50 K, 100 K, 300 K, and 1000 K 
Microsep™ Advance Centrifugal Devices purchased from the Pall Corporation. 
 
Synthesis 
Lanthanum fluoride (LaF3), lanthanum chloride (LaCl3), and lanthanum phosphate 
(LaPO4) nanocrystals were synthesized as follows at a temperature of 37 °C with stirring. 
The syringe pump injected the lanthanide mixture (20% terbium (III) nitrate hexahydrate, 
80% lanthanum (III) nitrate hexahydrate; 0.500 mL, 32.50 µmol, 65.0 mM) into a 
solution containing o-phosphorylethanolamine (3.25 mL, 260 µmol, 80.0 mM) and 0.125 
M NaF (3.25 mL, 812 µmol, 0.250 M), 1.00 M NaCl (3.25 mL, 6.50 mmol, 2.00 M), or 
Na3PO4 (3.25 mL, 162 µmol, 0.050 M) at a flow rate of 500 uL per minute. The samples 
 6 
were then incubated in a 37 °C shaker bath for 24 hours. The nanocrystal solutions were 
purified through centrifuge tubes with 3 K molecular weight cutoff membranes by 
centrifugation (4,000 rpm, 30 min, 4 X 10 mL H2O washes) to eliminate any free floating 
particles in solution too small to be the desired nanocrystals. This entire synthesis 
procedure was completed for solutions of pH 2, 3, 4, 5, 6, and 7.  
 
Size Separation 
Nanocrystal solutions were centrifuged (4,000 rpm, 30 min, 3 X 10 mL H2O washes) 
through membranes to separate out particles of specific molecular weight cutoff values (3 
K – 10 K (0.3 – 1 nm), 10 K – 50 K (1 – 5 nm), 50 K – 100 K (5 – 10 nm), 100 K – 300 
K (10 – 35 nm), 300 K – 1000 K (35 – 100 nm), and greater than 1000 K (> 100 nm) 
using Pall Microsep™ Advance Centrifugal Devices. 
 
Luminescence Analysis 
A PTI QuantaMaster-2 Spectrofluorometer was used to quantify luminescence. A 
reference scan of a Starna acrylic polymer reference cell with a polymethyl-methacrylate 
matrix was run in the spectrofluorometer with each set of data. This Starna acrylic 
polymer reference cell contains a stable reference material that allows luminescence 
scans from different days to be compared. Emission scans for each of the size-separated 
samples were run from 470 – 650 nm with an excitation of 350.5 nm. The luminescence 
values at 543 nm where a significant terbium peak was seen were used to compare 





The phosphorescence lifetime of all nanocrystals at each pH, counterion, and size range 
was taken using a Jasco FP-6500 Spectrofluorometer. Forty scans were taken for each 
sample using a bandwidth of 10 nm. The excitation wavelength was set to 350.5 nm, 
while the emission wavelength was set to 540 nm. The lifetime was measured using Jasco 
Phosophorescence Lifetime Measurement software Version 1.07.02.  
 
Results and Discussion 
Quantification of Proportions of Each Size Fraction of Terbium-Doped Lanthanum 
Nanocrystals Based on Counterion and pH 
This study aimed to look at the effect of both counterion used and pH of synthesis 
to see how this affected the size distribution of terbium-doped lanthanum nanocrystals. It 
was hypothesized that nanocrystals synthesized in low pH conditions would be larger in 
size than those formed in higher pH conditions, because the capping group, o-
phosphorylethanolamine, can be protonated at low pH values, preventing quick binding 
to the growing nanocrystals (Figure 1). Subsequently, the luminescence lifetimes of the 
nanocrystals were examined to give insight into effects of counterion, pH, and 
nanocrystals size on the quantum yield of these nanocrystals. 
Terbium-doped lanthanum nanocrystal synthesis efficiency was dependent on 
both counterion and pH of synthesis (Figure 2), as shown by fluorescence emission scan 
intensities that were run for all samples prior to size separation.  
 
Figure 2. Emission signal intensities for LaF
size separation at pH 2, 3, 4, 5, 6, and 7 at 543 nm quantified on PTI QuantaMaster
Spectrofluorometer with excitation at 350.5 nm.
 
In this study, it was assumed that signal intensities are indicative of relative 
amounts of each nanocrystal 
synthesis yield was found for pH 7 nanocrystals, which had a more than 3
in yield over all other nanocrystals synthesized at lower pH values for each counterion. 
The LaCl3 nanocrystals had a significantly lower synthesis yield overall, especially for 
pH 2, 3, 4, and 5 nanocrystals. All three counterions had increasing yield with increasing 
pH except LaCl3 nanocrystals at pH 3 and 4. It is possible that signal intensity was too 
low for the LaCl3 nanocrystals, resul
measurements was likely. Overall, it appears that pH 7 synthesis conditions result in 
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Following size separation, fluorescence emission scan intensities were taken for 
each size fraction. Figure 3a-
for the lanthanide fluorides, chlorides, and phosphates, respectively.
 
Figure 3. Graph showing the effect of pH on the percent of each size fraction synthesized 
for the 20% Tb LaF3 (a), LaCl
emission intensity at 543 nm quantified on PTI Quant
(excitation = 350.5 nm). Quantification of amounts of each size fraction was calculated 
assuming amount of nanocrystals created is proportional to luminescence.
 
Since amount of nanocrystals created was assumed to be proportion
luminescence, this provided a way to quantify the relative proportion of each size range 
created. The larger size fractions (5 
nanocrystals, regardless of the pH, while the smallest size fraction (< 5 
consistently only about 10% of the sample synthesized (Figure 3a). This may be due to 
































c shows how the percentages of size fractions vary with pH 
 




– 35 nm and > 35 nm) tended to dominate the LaF
nm) was 




. Because the lanthanide 
7 2 3 4 5 6 7 2 3 4
pH










fluorides are insoluble in water, the thermodynamic driving force will bring the fluoride 
and lanthanide ions together to make solid crystals. Hence, ions will readily attract one 
another to form crystals, and smaller crystals will be less likely to form since smaller 
crystals form from a fewer number of ions coming together. This issue may be combatted 
by using lower concentrations of reactants during synthesis in order to get smaller 
crystals forming throughout a more dilute solution. 
An opposite trend was seen for the LaCl3 nanocrystals (Figure 3b). The smaller 
size fractions tended to dominate the LaCl3 nanocrystals and a low proportion of the 
largest size fraction (greater than 35 nm) was synthesized, independent of pH (Figure 3b). 
LaCl3 is highly soluble (49.73 ± 0.02 wt % at 35 °C)
20
 and will thermodynamically be 
more likely to exist as ions in solution at equilibrium;
21
 therefore ions will not as readily 
attract one another to form a crystal structure, which could contribute to this result. In 
order to combat this solubility of the chlorides, a higher concentration of NaCl was used 
in the synthesis. However, the LaCl3 nanocrystals still had very low synthesis yields 
(Figure 2).  
While both the LaF3 and LaCl3 nanocrystals followed different trends than 
predicted by the hypothesis, that lower pH synthesis conditions would yield larger 
nanocrystals synthesized, the LaPO4 nanocrystals showed a trend that is consistent with 
this hypothesis (Figure 3c). As the pH decreased from pH 6 to 2, the proportion of the 
largest size fraction (greater than 35 nm) of LaPO4 nanocrystals increased, whereas the 
middle fraction (5 – 35 nm) decreased in proportion. Therefore, the LaPO4 nanocrystals 
were generally increasing in size as a function of decreasing pH. This result follows what 
was predicted in the hypothesis, that low pH nanocrystals will be larger in size than those 
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formed in higher pH solutions. When protonated, the capping group, o-
phosphorylethanolamine, will be less likely to bind to the lanthanide and stop crystal 
growth (Figure 1). In contrast, at more basic pH values, the phosphate on this capping 
group will likely be deprotonated, carrying a negative charge, which can bind to the 
lanthanide. Therefore, at low pH values, the crystals should be able to grow longer before 
the capping group stops them, yielding larger crystals. However, this trend was broken 
for pH 7 nanocrystals, which showed a large proportion of greater than 35 nm 
nanocrystals. This may be due to the fact that lanthanide phosphate has a pKa value at 
7.21.
21
 At about pH 7, 2 of the oxygens on the phosphate group will be deprotonated, 
allowing for quicker and more efficient binding to the lanthanide than at lower pH values. 
As predicted by Advanced Chemistry Development Software V11.0, the capping group 
does not have its second pKa value until 10.65,
22
 so will be less efficient at binding to the 
lanthanide than the phosphate counterion is. This effect of the phosphate counterion 
competing with the weak-base equilibrium of the capping group could influence this 
increase in size at pH 7. To verify that this may be the reason for this effect, a future 
study will look at relative size distributions of these nanocrystals as the pH of synthesis is 
increased to between 8 and 11 pH units. 
For the LaCl3 nanocrystals, the only weak acid-base equilibrium is that of the 
capping group. However, both fluoride and phosphate ions act as weak bases in 
solution.
21
 For this reason, when there are protons in solution, fluoride and phosphate 
ions may become protonated. When these anions are protonated, they will be unable to 
bind to the lanthanum or terbium cation, making lanthanide nanocrystals. We have to 
 
account for the acid-base behavior of both the capping
salt when explaining the size trends seen at var
It should be noted that error was significant between replicates of synthesized 
nanocrystals at particular pH values. Because there was significant variability in the data, 
this gives evidence that there are inconsistenci
and/or size separation. A more consistent method should be determined to try to reduce 
this variability between replicates so that data will have more validity. In addition, 
statistical tests must be conducted before any true differe
proportions of nanocrystals of different sizes may be claimed.
 
Fluorescent Lifetime Measurements of Each Size Frac
Nanocrystals Based on Counterion and pH
Figures 4, 5, and 6 show how the fluorescence l
fraction synthesized for the lanthanide fluorides, chlorides, and phosphates, respectively.
Figure 4. Effect of pH on fluorescence lifetime of size fractions of LaF
determined by a Jasco FP-6500 Spect
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It was found that the lifetime of LaF
(Figure 4). These nanocrystals showed increased lifetime values for the 35 
fractions, as well as the 10 – 
nm, had small lifetime values, but so did the largest size fraction, greater than 100 nm. 
Therefore it cannot be concluded that the lifetime is directly affected by the
particles, but there must be some other factor also playing a role. It does not appear that 
there is a pH dependence on lifetime measurement for these nanocrystals.
The LaCl3 nanocrystals showed a drastically different result, and lifetimes were 
relatively consistent across both size and pH (Figure 5).
 
Figure 5. Effect of pH on lifetime of size fractions of LaCl
by a Jasco FP-6500 Spectrofluorometer with excitation wavelength at 350.5 nm and 
emission wavelength at 540 nm.
 
The LaCl3 nanocrystals showed no pH or size fraction dependence upon size. Across both 
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smallest size fraction (0.3 – 1 nm) at pH 7. 
amount of error in lifetime measurement of this fraction of nanocrystals. The LaCl
nanocrystals showed different behavior than both the LaF
6) nanocrystals, yielding consistent lifetime data that was most reproducib
by the reduced error in these measurements when
nanocrystals synthesized. While the reason for this is not yet kn
from both the fluorides or phosphates because they do not show the 
equilibrium that the other two counterions do,
have more consistent luminescence lifetimes across pH and size. 
The LaPO4 nanocrystals did not have as consistent of lifetime measurements as 
did the LaCl3 nanocrystals, and a clear pH or size dependence was not found either 
(Figure 6). 
 
Figure 6. Effect of pH on lifetime of size fractions of LaPO
by a Jasco FP-6500 Spectrofluorometer with excitation wavelength at 350.5 nm and 
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The LaPO4 nanocrystals did not show a clear trend in lifetime measurement based on pH 
or size fraction (Figure 6). However, the smallest size fractions (0.3 – 1 nm, 1 – 5 nm, 
and 5 – 10 nm) showed relatively consistent lifetime measurements across pH of 
synthesis. This trend is not evident for the three larger size fractions, with the 10 – 35 nm 
size fraction showing the most lifetime variability across pH. For instance, the 10 – 35 
nm size fraction clearly has higher lifetime values at pH 5 and 6 than at pH 2. Data will 
be processed through Prism GraphPad statistical analysis software to determine if any 
lifetime measurements across pH or size fraction are significantly different; since some 
lifetime measurements did have a large amount of error, this makes conclusions about 
true lifetime differences indeterminate at this time. 
 
Conclusions 
 We have shown that the size of terbium-doped lanthanum nanocrystals is affected 
by both the pH of synthesis and the counterion used in the crystal structure. In order to 
use lanthanide nanocrystals for biological applications, the size of these particles must be 
carefully controlled such that particles are less than 6 nm so that they may exit the body 
through the kidneys. Based on the results of the size distribution of terbium-doped 
lanthanum nanocrystals, synthesis of fluoride and chloride terbium-doped lanthanum 
nanocrystals cannot be controlled by altering pH; however, terbium-doped lanthanum 
phosphate nanocrystals showed a pH dependence, giving evidence that pH of synthesis 
may be used to control the synthesis size of these nanocrystals. Future work will involve 
altering the temperature of synthesis to see how this effects the size distribution. Finding 
 16
the correct synthesis conditions to synthesize nanocrystals that are exclusively less than 6 
nm in size is an ultimate goal of this project. 
 A second goal of this project is to verify the assumption that the luminescence 
intensity measured on a spectrofluorometer is proportional to the amount of nanocrystals 
in solution. Measuring the lifetime of the lanthanide nanocrystals gives us insight into the 
quantum yield, or efficiency at emitting light, of these particles. Based on a quantum 
yield formula used by Du et al., the lifetime of these nanocrystals should be directly 
proportional to their quantum yield.
23
 A further direction of this research is to actually 
quantify the quantum yield of these nanoparticles. If there are differences in quantum 
yield that are dependent upon the pH or size of the nanocrystals, this must be 
implemented into the calculation of relative proportions of each size fraction of 
nanocrystal synthesized.  
In addition, lifetime results have interesting applications for creating lanthanide 
nanocrystals that are to be used as optical probes or other luminescent materials, since the 
best materials for these applications will be those which have the highest quantum yield. 
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